The Rho guanine dissociation inhibitor α inhibits skeletal muscle Rac1 activity and insulin action
Open Access
- 26 June 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (27)
Abstract
The molecular events governing skeletal muscle glucose uptake have pharmacological potential for managing insulin resistance in conditions such as obesity, diabetes, and cancer. With no current pharmacological treatments to target skeletal muscle insulin sensitivity, there is an unmet need to identify the molecular mechanisms that control insulin sensitivity in skeletal muscle. Here, the Rho guanine dissociation inhibitor α (RhoGDIα) is identified as a point of control in the regulation of insulin sensitivity. In skeletal muscle cells, RhoGDIα interacted with, and thereby inhibited, the Rho GTPase Rac1. In response to insulin, RhoGDIα was phosphorylated at S101 and Rac1 dissociated from RhoGDIα to facilitate skeletal muscle GLUT4 translocation. Accordingly, siRNA-mediated RhoGDIα depletion increased Rac1 activity and elevated GLUT4 translocation. Consistent with RhoGDIα’s inhibitory effect, rAAV-mediated RhoGDIα overexpression in mouse muscle decreased insulin-stimulated glucose uptake and was detrimental to whole-body glucose tolerance. Aligning with RhoGDIα’s negative role in insulin sensitivity, RhoGDIα protein content was elevated in skeletal muscle from insulin-resistant patients with type 2 diabetes. These data identify RhoGDIα as a clinically relevant controller of skeletal muscle insulin sensitivity and whole-body glucose homeostasis, mechanistically by modulating Rac1 activity.Keywords
Funding Information
- Lundbeck Foundation (R208-2015-3388)
- Danmarks Frie Forskningsfond (6108-00203)
- Danmarks Frie Forskningsfond (DFF-4004-00233)
- Gouvernement du Canada | Canadian Institutes of Health Research (FDN-143203)
- Novo Nordisk Fonden (10429)
- Novo Nordisk Fonden (15182)
- Novo Nordisk Fonden (NNF16OC0023418)
- Novo Nordisk Fonden (NNF18OC0032082)
- Lundbeck Foundation (R322-2019-2688)
This publication has 60 references indexed in Scilit:
- Metabolic Syndrome and Risk of CancerDiabetes Care, 2012
- Cross talk between mitochondria and NADPH oxidasesFree Radical Biology and Medicine, 2011
- The 'invisible hand': regulation of RHO GTPases by RHOGDIsNature Reviews Molecular Cell Biology, 2011
- Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1Nature Cell Biology, 2010
- Differential Phosphorylation of RhoGDI Mediates the Distinct Cycling of Cdc42 and Rac1 to Regulate Second-phase Insulin SecretionJournal of Biological Chemistry, 2010
- Effects of contraction on localization of GLUT4 and v-SNARE isoforms in rat skeletal muscleAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational ModificationJournal of Biological Chemistry, 2008
- GEFs and GAPs: Critical Elements in the Control of Small G ProteinsCell, 2007
- In Vivo Dynamics of Rac-Membrane InteractionsMolecular Biology of the Cell, 2006
- GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factorsNature Reviews Molecular Cell Biology, 2005